FDA notified healthcare professionals that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin). Due to the serious nature of PML, a new Boxed Warning highlighting this risk has been added to the drug label. [...]
Continue reading...10. January 2012
A new side effect seems to be emerging for those cholesterol-lowering wonder drugs called statins: They may increase some people’s chances of developing Type 2 diabetes. The best-selling statin is atorvastatin, marketed as Lipitor and Torvast. A number of statins are on the market: atorvastatin (Lipitor and Torvast), fluvastatin (Lescol), lovastatin (Mevacor, Altocor, Altoprev), pitavastatin [...]
Continue reading...9. January 2012
Diabetes drug Actos has been linked to high risk of bladder cancer and other injuries. Recent medical studies confirm that Actos can cause bladder cancer and other injuries. Actos (pioglitazone) is a Type 2 diabetes drug often prescribed as an alternative to Avandia. At one time it was believed that Actos was safer. Actos lawsuits against Takeda [...]
Continue reading...22. December 2011
U.S. Food and Drug Administration has completed a safety review of Multaq (generic name dronedarone). According to this review, in patients with permanent atrial fibrillation (AF), Multaq increased the risk of serious cardiovascular events, including death. The data was obtained from ATHENA and PALLAS clinical trials. New information and recommendations are being provided by FDA for [...]
Continue reading...17. November 2011
Actos is a Type 2 diabetes drug which has been linked to an increased risk of heart attack, congestive heart failure, heart disease and death. It has also been linked to an increased risk of bladder cancer, rhabdomyolysis (kidney damage), liver damage, and bone fracture. Here is an updated list of drugs with active ingredient [...]
Continue reading...3. November 2011
The Diabetes drug Actos has been linked to high risk of bladder cancer and other injuries. Common Symptops: Dark urine Frequent urination Painful urination Urinary tract infection Drugs effected Generic name: Pioglitazone Actos ACTOplus met ACTOplus met XR duetact NDC numbers found on Actos packaging: 00247-1924-30 00247-1925-30 00247-1926-30 12280-0060-30 13411-0101-03 13411-0102-03 13411-0103-03 21695-0147-15 21695-0148-15 49999-0450-30 49999-0451-30 54569-4880-00 [...]
Continue reading...11. August 2011
Pregnant women who take selective serotonin reuptake inhibitors (SSRIs) may be putting their babies at risk for heart defects. SSRIs, which are normally used to treat obsessive-compulsive disorders, anxiety disorders, and depression, have also been linked to heart defects in infants. The risk appears greatest when pregnant women take the drugs in the later part [...]
Continue reading...9. August 2011
Selective serotonin reuptake inhibitors (also known as SSRIs) have been linked to various birth defects in infants whose mothers took the drugs while pregnant. SSRIs are often prescribed to treat patients with various conditions related to anxiety, depression, and obsessive-compulsive disorder. While SSRIs cause a number of side effects in people who take them, mothers [...]
Continue reading...3. August 2011
A drug used to treat yeast infections may be linked to certain birth defects in infants whose mothers took the drug during their pregnancies. Taking frequent, high does of the drug Diflucan (generic name fluconazole) while pregnant has been shown to increase health risks in newborn babies. The risk appears especially great when mothers take [...]
Continue reading...2. August 2011
Side effects of the antidepressant Zoloft range from simple nausea to severe birth defects that can only be treated by surgery. While some side effects are uncommon, patients should exercise caution while taking Zoloft and report to their doctors if any unexpected side effects appear. Along with nausea, common side effects of taking the drug [...]
Continue reading...
13. January 2012
0 Comments